ALMSAlumis Inc.
$6.79+47% 1Y
$6.79
$4.4952 weeks$30.31
Is the price fair?
What ALMS's price assumes
Alumis Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 485× revenue.
485
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 7.94
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 7.94
- EV / EBIToperating margin −6204%: the multiple describes the denominator
- not meaningful
- Market capitalisation129.4 million shares, counted Aug 6, 2026
- $879M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry